Management of Cytopenias During Treatment with Lenalidomide in Patients with Myelodysplastic Syndromes
2010 ◽
Vol 3
(1)
◽
pp. 43-46
2000 ◽
Vol 111
(3)
◽
pp. 863-872
◽
Yayoi Shikama
◽
Tsutomu Shichishima
◽
Hitoshi Ohto
◽
Paul T. Jubinsky
◽
Human medicines European public assessment report (EPAR): Azacitidine Accord, azacitidine, Myelodysplastic Syndromes,Leukemia, Myelomonocytic, Chronic,Leukemia, Myeloid, Acute, Date of authorisation: 13/02/2020, Status: Authorised
Stephen Nimer
◽
Xinyang Zhao